Effects of Micro-Interventions on Stress Reactivity

The Effects of Brief, Psychological Interventions (Micro-Interventions) on the Individual Stress Reactivity

This study aims to investigate the effects of short, psychological interventions on bio-psychological stress responses after an acute stressor. The efficacy of two different approaches (expectation-bases vs. acceptance-based) will be compared to a control-group.

Study Overview

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Marburg, Germany, 35032
        • Philipps University Marburg Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • fluent in German language

Exclusion Criteria:

  • chronic disease
  • mental disease
  • the evening before the day of the experiment until end of the experiment (the next day):
  • caffeine, alcohol, intensive physical exercise, chewing gum
  • acute hay fever
  • current intake of psychotropic medication
  • current intake of orale contraceptives
  • visual impairments
  • heart conditions (self and close relatives)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Expectation
Participants are asked to think of three strength which have helped them in prior stressful events. They then have to think of ways how these strength may help them in future stressful situations, i.e. a test in this experiment.
writing task
Experimental: Acceptance
Participants listen to an audio-instruction on cognitive defusion. They shall observe the thoughts and feelings of stress and, with the help of the instruction, distance themselves from it.
listening
No Intervention: Control
Participants wait for the stress-test to start.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Subjective Stress Ratings
Time Frame: at baseline, before the intervention, after the intervention; during the stressor, after the stressor; in total 45 minutes
VAS (visual analogue scale)
at baseline, before the intervention, after the intervention; during the stressor, after the stressor; in total 45 minutes
Change in Cortisol Levels
Time Frame: at baseline (min. -37), after the intervention (min. -19), after the stressor (min. 0), recovery 1 (min. +15), recovery 2 (min. +30); in total 67 minutes
saliva sample
at baseline (min. -37), after the intervention (min. -19), after the stressor (min. 0), recovery 1 (min. +15), recovery 2 (min. +30); in total 67 minutes
Changes in Heart-Rate-Variability (HRV)
Time Frame: during baseline (duration 10 minutes), during the stressor (duration 20 minutes), during recovery (duration 10 minutes); in total 40 minutes
electrocardiogram
during baseline (duration 10 minutes), during the stressor (duration 20 minutes), during recovery (duration 10 minutes); in total 40 minutes
Changes in Affect
Time Frame: at baseline, after the stressor; in total 45 minutes
VAS (visual analogue scale)
at baseline, after the stressor; in total 45 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Efficacy
Time Frame: at baseline, after the recovery-phase; in total 55 minutes
questionnaire (self-efficacy scale; Schwarzer & Jerusalem, 1999)
at baseline, after the recovery-phase; in total 55 minutes
Positivity
Time Frame: at baseline, after the recovery-phase; in total 55 minutes
questionnaire (positivity scale; Caprara et al., 2012, König, 2012)
at baseline, after the recovery-phase; in total 55 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Frank Euteneuer, Prof. Dr., Philipps University Marburg Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2019

Primary Completion (Actual)

October 19, 2020

Study Completion (Actual)

October 19, 2020

Study Registration Dates

First Submitted

November 8, 2019

First Submitted That Met QC Criteria

November 18, 2019

First Posted (Actual)

November 20, 2019

Study Record Updates

Last Update Posted (Actual)

July 2, 2021

Last Update Submitted That Met QC Criteria

July 1, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019-54k

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Stress

Clinical Trials on Expectation

3
Subscribe